Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Treg and neutrophil extracellular trap interaction contributes to the development of immunosuppression in sepsis
Yuxin Shi, Dan Wu, Yanghanzhao Wang, Yuwen Shao, Fu Zeng, Di Zhou, Hao Zhang, Changhong Miao
Yuxin Shi, Dan Wu, Yanghanzhao Wang, Yuwen Shao, Fu Zeng, Di Zhou, Hao Zhang, Changhong Miao
View: Text | PDF
Research Article Immunology Inflammation

Treg and neutrophil extracellular trap interaction contributes to the development of immunosuppression in sepsis

  • Text
  • PDF
Abstract

The excessive formation and release of neutrophil extracellular traps (NETs) in sepsis may represent a substantial mechanism contributing to multiorgan damage, which is associated with a poor prognosis. However, the precise role of NETs in mediating the transition from innate immunity to adaptive immunity during the progression of inflammation and sepsis remains incompletely elucidated. In this study, we provide evidence that, despite a reduction in the number of CD4+ T cells in the late stage of sepsis, there is a notable upregulation in the proportion of Tregs. Mechanistically, we have identified that NETs can induce metabolic reprogramming of naive CD4+ T cells through the Akt/mTOR/SREBP2 pathway, resulting in enhanced cholesterol metabolism, thereby promoting their conversion into Tregs and augmenting their functional capacity. Collectively, our findings highlight the potential therapeutic strategy of targeting intracellular cholesterol normalization for the management of immunosuppressed patients with sepsis.

Authors

Yuxin Shi, Dan Wu, Yanghanzhao Wang, Yuwen Shao, Fu Zeng, Di Zhou, Hao Zhang, Changhong Miao

×

Figure 4

NETs enhance cholesterol metabolism in Tregs through the SREBP2 pathway.

Options: View larger image (or click on image) Download as PowerPoint
NETs enhance cholesterol metabolism in Tregs through the SREBP2 pathway....
(A) Top enriched pathways in NET-treated naive CD4+ T cells, compared with those in the nontreated group. (B) Heatmap of naive CD4+ T cells with or without NET treatment in cholesterol homeostasis. (C) Western blot images of SREBP2-regulated gene expression in naive CD4+ T cells. (D) The relative gene expression of SREBP2-regulated gene expression in naive CD4+ T cells. (E) Filipin staining of naive CD4+ T cells treated with or without NETs. Scale bars: 50 μm. (F) iTreg differentiation in NET-treated or control group with or without fatostatin treatment (n = 5). Each bar represents mean ± 95% CI. Data comparison between 2 groups was analyzed by unpaired t test. Statistical analysis for 3 or more groups was preformed using 1-way ANOVA. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts